XML 37 R28.htm IDEA: XBRL DOCUMENT v3.10.0.1
Intangible Assets (Tables)
9 Months Ended
Jun. 30, 2018
Goodwill and Intangible Assets Disclosure [Abstract]  
Components of Intangible Assets
Intangible assets consisted of:
 
June 30, 2018
 
September 30, 2017
(Millions of dollars)
Gross
Carrying
Amount
 
Accumulated
Amortization
 
Gross
Carrying
Amount
 
Accumulated
Amortization
Amortized intangible assets
 
 
 
 
 
 
 
Developed technology
$
13,937

 
$
1,636

 
$
3,508

 
$
1,029

Customer relationships
4,585

 
781

 
3,393

 
564

Product rights
121

 
56

 
131

 
54

Trademarks
407

 
79

 
408

 
65

Patents and other
388

 
283

 
370

 
274

Amortized intangible assets
$
19,439

 
$
2,836

 
$
7,811

 
$
1,986

Unamortized intangible assets
 
 
 
 
 
 
 
Acquired in-process research and development
$
37

 
 
 
$
67

 
 
Trademarks
2

 
 
 
2

 
 
Unamortized intangible assets
$
39

 
 
 
$
69

 
 
Reconciliation of Goodwill by Business Segment
The following is a reconciliation of goodwill by business segment:
(Millions of dollars)
Medical
 
Life Sciences
 
Interventional
 
Total
Goodwill as of September 30, 2017
$
6,802

  
$
761

 
$

  
$
7,563

Acquisitions (a)
4,389

 
76

 
10,674

 
15,139

Divestitures

 

 
(55
)
 
(55
)
Reallocation of goodwill for change in segment and reporting unit composition (b)
(877
)
 

 
877

 

Purchase accounting adjustments (c)
216

 

 
661

 
878

Currency translation
(19
)
 
(1
)
 

 
(20
)
Goodwill as of June 30, 2018
$
10,511

  
$
836

 
$
12,157

  
$
23,505


(a)
Represents goodwill primarily recognized upon the Company's acquisition of Bard, which is further discussed in Note 8. Also includes goodwill recognized relative to certain acquisitions which were not material individually or in the aggregate.
(b)
Represents the reassignment of goodwill, determined based upon a relative fair value allocation approach, associated with the movement of certain product offerings which were previously reported in the Medical segment and which are now reported in the Interventional segment as further discussed in Note 6.
(c)
The purchase accounting adjustments increasing goodwill were primarily driven by the valuation of Bard developed technology assets, the associated deferred tax liability changes, increases to legal reserves and the alignment of the combined organization's accounting policies with respect to accrued liabilities and other accounts.